Shares of Integer Holdings Corp (NYSE:ITGR) have received an average rating of “Buy” from the eight analysts that are presently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $77.75.

Several brokerages have issued reports on ITGR. Zacks Investment Research downgraded shares of Integer from a “buy” rating to a “hold” rating in a research report on Wednesday, September 12th. TheStreet raised shares of Integer from a “c+” rating to a “b” rating in a research report on Monday, August 6th. Royal Bank of Canada reaffirmed a “hold” rating and issued a $72.00 price objective on shares of Integer in a research report on Friday, August 3rd. Northcoast Research raised shares of Integer to a “buy” rating and set a $83.00 price objective for the company in a research report on Friday, July 20th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $78.00 price objective (up previously from $65.00) on shares of Integer in a research report on Friday, July 6th. They noted that the move was a valuation call.

In other news, COO Jeremy Friedman sold 1,515 shares of the firm’s stock in a transaction that occurred on Tuesday, August 14th. The shares were sold at an average price of $70.92, for a total transaction of $107,443.80. Following the completion of the sale, the chief operating officer now owns 3,648 shares of the company’s stock, valued at $258,716.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jennifer M. Bolt sold 19,413 shares of the firm’s stock in a transaction that occurred on Tuesday, August 21st. The stock was sold at an average price of $73.11, for a total transaction of $1,419,284.43. Following the sale, the insider now directly owns 18,680 shares of the company’s stock, valued at approximately $1,365,694.80. The disclosure for this sale can be found here. Insiders sold 107,311 shares of company stock valued at $8,201,676 in the last ninety days. 3.60% of the stock is owned by corporate insiders.

Hedge funds have recently added to or reduced their stakes in the company. Point72 Hong Kong Ltd acquired a new stake in shares of Integer during the second quarter worth approximately $111,000. Mount Yale Investment Advisors LLC acquired a new stake in shares of Integer during the first quarter worth approximately $140,000. Federated Investors Inc. PA grew its position in shares of Integer by 236.3% during the second quarter. Federated Investors Inc. PA now owns 2,411 shares of the medical equipment provider’s stock worth $156,000 after buying an additional 1,694 shares in the last quarter. BlueMountain Capital Management LLC acquired a new stake in shares of Integer during the second quarter worth approximately $194,000. Finally, Verition Fund Management LLC acquired a new stake in shares of Integer during the first quarter worth approximately $200,000. 96.18% of the stock is owned by institutional investors and hedge funds.

NYSE ITGR traded down $2.80 during mid-day trading on Monday, hitting $79.75. The company’s stock had a trading volume of 234,000 shares, compared to its average volume of 213,218. Integer has a 52-week low of $42.50 and a 52-week high of $82.75. The company has a debt-to-equity ratio of 1.64, a quick ratio of 2.95 and a current ratio of 3.80. The firm has a market capitalization of $2.59 billion, a price-to-earnings ratio of 28.59 and a beta of 0.83.

Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, August 2nd. The medical equipment provider reported $1.06 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.88 by $0.18. Integer had a net margin of 6.63% and a return on equity of 12.60%. The firm had revenue of $313.00 million for the quarter, compared to analyst estimates of $379.41 million. During the same quarter last year, the firm posted $0.62 earnings per share. Integer’s revenue for the quarter was up 11.4% compared to the same quarter last year. sell-side analysts forecast that Integer will post 3.57 EPS for the current fiscal year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates through two segments, Medical and Non-Medical. The company offers arthroscopic devices and components, such as shaver blades and burrs, ablation probes, and suture anchors; laparoscopic and general surgery products, including trocars, endoscopes and laparoscopes, closure devices, harmonic scalpels, bipolar energy delivery devices, radio frequency probes, thermal tumor ablation devices, and ophthalmic surgery devices; and biopsy and drug delivery products.

Featured Story: What is Considered a Good Return on Equity (ROE)?

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.